View in EDS HTML Full Text PDF Full Text

Prognostic modeling for diffuse midline glioma: development and validation of a risk stratification nomogram using SEER and institutional cohorts.

Saved in:
Bibliographic Details
Title: Prognostic modeling for diffuse midline glioma: development and validation of a risk stratification nomogram using SEER and institutional cohorts.
Authors: Zhang G; Department of Radiotherapy, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China., Zhou H; Department of Radiotherapy, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.; Hebei Key Laboratory of Etiology Tracing and Individualized Diagnosis and Treatment for Digestive System Carcinoma, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.; Department of Central Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China., Han W; Department of Radiotherapy, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China., Lou L; Department of Pathology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China., Xue X; Department of Radiotherapy, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.; Hebei Key Laboratory of Etiology Tracing and Individualized Diagnosis and Treatment for Digestive System Carcinoma, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Source: Frontiers in oncology [Front Oncol] 2025 Oct 27; Vol. 15, pp. 1644388. Date of Electronic Publication: 2025 Oct 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1644388